HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Xiao-Jing Wang Selected Research

Keratin-5 (Keratin 5)

12/2014Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice.
4/2013Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis.
1/2012The pro-inflammatory role of TGFβ1: a paradox?
2/2010A role for TGFbeta signaling in the pathogenesis of psoriasis.
4/2004Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Xiao-Jing Wang Research Topics

Disease

28Neoplasms (Cancer)
03/2015 - 07/2004
12Inflammation
03/2015 - 04/2004
11Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2014 - 07/2004
6Psoriasis (Pustulosis Palmaris et Plantaris)
01/2013 - 04/2004
5Schizophrenia (Dementia Praecox)
01/2015 - 10/2008
4Wounds and Injuries (Trauma)
05/2014 - 09/2006
4Periodontitis
04/2013 - 05/2010
3Fibrosis (Cirrhosis)
12/2014 - 07/2004
3Neoplasm Metastasis (Metastasis)
10/2013 - 08/2004
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2015 - 12/2009
2Medulloblastoma
04/2015 - 01/2015
2Stomatitis
03/2015 - 04/2013
2Pneumonia (Pneumonitis)
12/2014 - 08/2013
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 04/2012
2Leukemia
04/2014 - 12/2004
2Anoxia (Hypoxia)
01/2014 - 08/2013
2Infection
08/2013 - 08/2013
2Head and Neck Neoplasms (Head and Neck Cancer)
06/2013 - 04/2009
2Melanoma (Melanoma, Malignant)
05/2013 - 01/2011
2Prostatic Neoplasms (Prostate Cancer)
01/2013 - 01/2013
2Hyperplasia
01/2013 - 08/2004
2Breast Neoplasms (Breast Cancer)
06/2012 - 08/2010
2Skin Neoplasms (Skin Cancer)
01/2010 - 07/2005
2Hypersensitivity (Allergy)
06/2009 - 07/2007
2Skin Diseases
04/2009 - 04/2004
2Carcinoma (Carcinomatosis)
07/2005 - 12/2004
2Papilloma (Papillomatosis)
07/2005 - 11/2004
1Cerebral Hemorrhage
09/2015
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
09/2015
1Cleidocranial Dysplasia (Cleidocranial Dysostosis)
09/2015
1Stroke (Strokes)
09/2015
1Lung Diseases (Lung Disease)
12/2014
1Lung Injury
12/2014
1Lung Neoplasms (Lung Cancer)
10/2014
1Mental Retardation (Idiocy)
01/2014
1Actinic Keratosis
11/2013
1Schistosomiasis (Bilharziasis)
09/2013
1Pulmonary Hypertension (Ayerza Syndrome)
09/2013
1Acquired Immunodeficiency Syndrome (AIDS)
08/2013
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2013
1Autoimmune Diseases (Autoimmune Disease)
08/2013
1Squamous Cell Neoplasms (Squamous Cell Cancer)
08/2013
1Lymphoma (Lymphomas)
08/2013

Drug/Important Bio-Agent (IBA)

14Transforming Growth Factor beta (TGF-beta)IBA
02/2010 - 07/2004
6Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2009 - 04/2004
5Transforming Growth Factors (Transforming Growth Factor)IBA
03/2015 - 11/2004
5Keratin-5 (Keratin 5)IBA
12/2014 - 04/2004
5Cadherins (E-Cadherin)IBA
05/2014 - 07/2005
4Messenger RNA (mRNA)IBA
04/2015 - 01/2013
4NicotineFDA Link
04/2013 - 05/2010
3Proteins (Proteins, Gene)IBA
09/2015 - 11/2009
3Phosphotransferases (Kinase)IBA
04/2015 - 08/2004
3NF-kappa B (NF-kB)IBA
03/2015 - 05/2007
3Glutamic Acid (Glutamate)FDA Link
01/2015 - 10/2012
3CollagenIBA
12/2014 - 07/2004
3AntigensIBA
04/2014 - 12/2009
3MicroRNAs (MicroRNA)IBA
08/2013 - 01/2012
3Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
04/2013 - 05/2010
3transforming growth factor-beta type II receptorIBA
04/2012 - 07/2005
2tyrosine receptor (receptor, tyrosine)IBA
04/2015 - 01/2015
2LigandsIBA
04/2015 - 01/2015
2Bleomycin (Blenoxane)FDA LinkGeneric
12/2014 - 07/2004
2Adenocarcinoma of lungIBA
10/2014 - 04/2012
2KetamineFDA LinkGeneric
04/2014 - 01/2013
2HLA-DRB1 antigen (HLA DRB1)IBA
04/2014 - 12/2009
2Interleukin-13IBA
09/2013 - 01/2008
2Carrier Proteins (Binding Protein)IBA
05/2013 - 01/2011
2CytokinesIBA
04/2013 - 01/2008
2Small Interfering RNA (siRNA)IBA
01/2013 - 06/2012
2N-Methylaspartate (NMDA)IBA
01/2013 - 10/2012
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2012 - 10/2008
2Keratins (Keratin)IBA
01/2010 - 08/2004
1polyalanineIBA
09/2015
1Tissue Plasminogen Activator (Alteplase)FDA Link
09/2015
1cadherin 5IBA
09/2015
1Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2015
1tetramethylpyrazineIBA
05/2015
1EphB1 ReceptorIBA
04/2015
1Ovarian epithelial cancerIBA
01/2015
1Ephrin-A5 (Ephrin A5)IBA
01/2015
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2015
1indium-bleomycinIBA
12/2014
1cyclopamineIBA
12/2014
1tensins (tensin)IBA
10/2014
1HLA-A Antigens (HLA-A)IBA
04/2014
1HLA-B Antigens (HLA-B)IBA
04/2014
1SodiumIBA
01/2014
1ranolazineFDA Link
01/2014
1Ethanol (Ethyl Alcohol)IBA
01/2014
1Smad4 ProteinIBA
11/2013
1Idiopathic pulmonary hypertensionIBA
09/2013
1Interleukin-4 (Interleukin 4)IBA
09/2013
1PX-866IBA
08/2013

Therapy/Procedure

3Drug Therapy (Chemotherapy)
03/2015 - 01/2011
2Radiotherapy
12/2014 - 07/2011
2Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2013 - 08/2010
2Heterologous Transplantation (Xenotransplantation)
06/2013 - 07/2011
2Subcutaneous Injections
06/2009 - 07/2004
1Therapeutics
08/2013
1Transplants (Transplant)
08/2013